Neuromodulation for Lower Urinary Tract Dysfunction: Mechanisms, Modalities, and Patient Selection
International Urogynecology Journal · 05.08.2026
DOI: 10.1007/s00192-026-06836-9 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Urogynecology Journal, online erschienen am 05.08.2026. Verfasst von Yukun Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, School of Medicine, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, Zhejiang, 310016, P.R. China. Die Arbeit nennt 99 Literaturangaben. Gefördert von: Zhejiang Province Traditional Chinese Medicine Science and Technology Project.
Abstract (Originalsprache)
Purpose
Lower urinary tract dysfunction (LUTD) includes urgency, frequency, urgency urinary incontinence, voiding symptoms, and nonobstructive urinary retention, with many patients remaining symptomatic after behavioral and pharmacologic therapy. Neuromodulation has a distinct role because it targets aberrant reflex activity and sensory signaling in pelvic afferent pathways and spinal–supraspinal circuits rather than directly altering detrusor contractility or outlet resistance.
Methods
This narrative review synthesizes PubMed/MEDLINE literature, major urological guidelines, and evidence syntheses up to May 2026. Evidence was prioritized by methodological robustness and qualitatively synthesized by modality, LUTD phenotype, durability, treatment burden, safety, and clinical relevance.
Results
Sacral neuromodulation (SNM) is the most established implant-based approach, with reported 5-year success of approximately 67–82% in non-neurogenic overactive bladder (OAB), although long-term benefit depends on testing, revision risk, and repeated programming. Smaller and rechargeable pulse generators, MRI-conditional systems, and multi-contact leads are reducing historical barriers and enabling more flexible programming; randomized evidence suggests electrode design can improve short-term response. Tibial nerve stimulation has expanded across clinic-based and home-based workflows. Percutaneous tibial nerve stimulation improves OAB symptoms in sham-controlled trials but requires ongoing visits and maintenance dosing. Transcutaneous approaches reduce procedural burden, although protocol heterogeneity limits comparisons. Implantable tibial neuromodulation provides scheduled home stimulation and shows durable 2-year responder rates in pivotal studies, but comparisons with SNM remain largely indirect. Safety data generally show minor, reversible adverse events.
Conclusion
Neuromodulation is an important LUTD treatment, but better patient selection, neurogenic risk stratification, standardized outcomes, comparative studies, and physiology-guided programming remain priorities.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, School of Medicine, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, Zhejiang, 310016, P.R. China.
- Department of Pelvic Floor Rehabilitation Center & Department of Colorectal Surgery, Sir Run Run Shaw Hospital of Zhejiang University, No.3 East Qingchun Road, Zhejiang Province, Hangzhou, 310016, China.
- The Second School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, 310053, P.R. China.
- Department of Colorectal Surgery, School of Medicine, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, Zhejiang, 310016, P.R. China.
- Department of Pelvic Floor Rehabilitation Center & Department of Colorectal Surgery, Sir Run Run Shaw Hospital of Zhejiang University, No.3 East Qingchun Road, Zhejiang Province, Hangzhou, 310016, China. Weizhou_srrsh@z…
- Department of Colorectal Surgery, School of Medicine, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, Zhejiang, 310016, P.R. China. Weizhou_srrsh@zju.edu.cn.
Förderung
- Zhejiang Province Traditional Chinese Medicine Science and Technology Project
Zitieren
APA
Wang, Y., Shan, J., Chen, E., Xu, K., Zhou, W., & Shan, L. (2026). Neuromodulation for Lower Urinary Tract Dysfunction: Mechanisms, Modalities, and Patient Selection. International Urogynecology Journal. https://doi.org/10.1007/s00192-026-06836-9
Vancouver
Wang Y, Shan J, Chen E, Xu K, Zhou W, Shan L. Neuromodulation for Lower Urinary Tract Dysfunction: Mechanisms, Modalities, and Patient Selection. International Urogynecology Journal. 2026. doi:10.1007/s00192-026-06836-9
BibTeX
@article{Wang2026,
author = {Wang, Yukun and Shan, Jinlin and Chen, Engeng and Xu, Kai and Zhou, Wei and Shan, Lina},
title = {Neuromodulation for Lower Urinary Tract Dysfunction: Mechanisms, Modalities, and Patient Selection},
journal = {International Urogynecology Journal},
year = {2026},
doi = {10.1007/s00192-026-06836-9}
}
EUVIMED